Searched for
DENGUE VACCINE INDIA
QDENGA dengue vaccine to hit India market in 2027; Dr Reddy’s to sell itIndia's first approved dengue vaccine, QDENGA, will launch in the private market by mid-2027. Dr Reddy's Laboratories will distribute and p...
Demand for vaccines surges as H1N1, other influenza cases see a sharp riseDemand for flu vaccines has significantly increased this year. At-home vaccination services are seeing a substantial rise in bookings. Rapi...
Corporates urge employees to stay alert as H1N1 cases surgeH1N1 cases have increased significantly, and monsoon fevers are at seasonal highs. Companies are issuing safety guidelines and advising emp...
Japan's Takeda bets on dengue vax to reshape India playbookTakeda Pharmaceutical's new dengue vaccine Qdenga received approval in India. The vaccine is expected to launch commercially in early 2027....
Comprehensive health insurance: Navigating childhood illnesses, vaccination support, and kidney function careHealth insurance covers childhood illnesses and their treatments effectively. Vaccination support is a key preventive care strategy for fam...
ICMR maps dengue strains nationwide as India eyes vaccine rolloutIndia's first dengue vaccine is nearing rollout as a study maps circulating virus strains. All four dengue serotypes are now circulating si...
Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in IndiaIndia's drug regulator has approved Takeda's Qdenga dengue vaccine, the first of its kind. This vaccine is expected to become available in ...
School Assembly News Headlines Today July 21: Top National, International, Sports, Business events that students should knowSchool Assembly News Headlines Today July 21: Parliament faced disruptions as opposition demanded discussions on alleged paper leaks. Heavy...
Takeda Biopharmaceuticals gets DCGI nod for dengue vaccine QDENGATakeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individua...
Takeda to launch dengue vaccine in India next yearTakeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration with Biological ...
In a medical breakthrough, first phase-3 dengue vaccine trial begins in IndiaIndia started its inaugural phase 3 clinical trial for the DengiAll dengue vaccine, developed by Panacea Biotec. The trial will include 10,...
First-ever phase-three clinical trial for dengue vaccine initiated in IndiaThe Indian Council of Medical Research (ICMR) and Panacea Biotec have launched the first phase three clinical trial for an indigenous dengu...
CDSCO panel gives nod for continuation of phase-II clinical trial of SII's dengue vaccineAn expert committee recommended continuation of phase-II clinical trial of Serum Institute of India's vaccine against dengue after successf...
Takeda to soon start trials in India for dengue vaccineTakeda Pharmaceuticals' dengue vaccine assumes significance since the first vaccine ever licensed for dengue, developed by French drugmaker...
Shared latest data on dengue vaccine with authorities: SanofiYesterday, the Philippines government ordered an investigation into the immunisation of more than 7.3 lakh children with the company's deng...
Sun Pharma partners ICGEB to develop safer, cheaper dengue vaccineThis is the Mumbai-based company’s second collaboration focussed on the mosquito-borne virus, the first being its pact to develop a botanic...
Sun Pharma, ICGEB tie up to develop dengue vaccineSun Pharma will fund and support further development of the vaccine candidate and existing ICGEB knowhow and patents.
Why India is struggling to introduce dengue vaccinesThe ICGEB plans a larger vaccine trial on monkeys in America; the full-fledged human trial after that could cost more than Rs 100 crore.
World's 1st dengue vaccine likely by 2015: SanofiCountry Head, Sanofi Pasteur, Stephan Barth, said dengue is a serious health concern in India, causing a significant but under-reported bur...
Dengue vaccine tested on Indian adults, found safeThe study showed that 87% of Indian adults in trial were positive to dengue at enrolment, confirming the significant endemic nature of the ...